Identifier	Label	References	Description
HBP00001	microtubule-binding region	pmid:18500754, pmid:2516729,  	The motif in the MAPT protein where microtubule binding repeats
HBP00002	tubulin-binding repeat 1	pmid:18500754	position 569_591 of canonical isoform of MAPT protein
HBP00003	tubulin-binding repeat 2	pmid:18500754	position 592_621 of canonical isoform of MAPT protein
HBP00004	tubulin-binding repeat 3	pmid:18500754	position 623_653 of canonical isoform of MAPT protein
HBP00005	tubulin-binding repeat 4	pmid:18500754	position 654_685 of canonical isoform of MAPT protein
HBP00006	Tau aggregates	pmc:PMC2633703	Tau (MAPT) in its aggregated form (as Paired Helical Filaments (PHFs) or Straight Filaments (SF)) contains 5–9 moles of phosphate/ mole of the protein, defining it as hyper phosphorylated
HBP00007	hyperphosphorylation	pmid:22710920	An excessive phosphorylation (see GO:0006468)
HBP00008	GAL80TS	pmid:PMC3073608	temperature-sensitive allele of GAL80 (tub-GAL80TS)  
HBP00009	Tau oligomers	pmid:PMC4828294	CAST is known to prevent oligomerization of Tau (Rao et al., 2014) and α-synuclein (Diepenbroek et al. 2014) and inhibit reactive gliosis (Rao et al., 2008)
HBP00010	LY293002	pmid:21329734	a specific PI3-kinase inhibitor 
HBP00011	LPLI	pmid:20333643	Low-power laser irradiation (LPLI) is a non-damage physical therapy
HBP00012	Chronic cerebral hypoperfusion	pmid24575038	Chronic cerebral hypoperfusion (CCH) is one of the causes of vascular dementia (VaD) and is also an etiological factor for Alzheimer's disease (AD)
HBP00013	Mori Fructus ethanol extract	pmid:26068423	ethanol extracted from Mori Fructus, a well-known traditional herbal medicine, food, and dietary supplement
HBP00014	tunneling nanotubes	pmid:27809932	filamentous-actin-containing membranous structures that bridge and connect cells
HBP00015	amyloidogenesis 	pmid:24653673	production of amyloid
HBP00016	alpha-synuclein aggregates	pmid:23254192	alpha-synuclein (SNCA) aggregate in fibrillar or oligomeric forms, usually found in Lewy bodies
HBP00017	huntingtin aggregates	pmid:12747895	huntingtin (HTT) protein fragments aggregations
HBP00018	amyloid-beta aggregates	pmid:23484434	aggregation of amyloid-beta fragments of the APP protein
HBP00019  APP C-terminally truncated carboxyl-terminal fragments  pmid:15491160 C-terminally truncated carboxyl-terminal fragments (CTFs) of APP
HBP00020  A2B5 antigen  pmid:14976144 A2B5 antigen is a cell surface ganglioside epitope expressed on developing thymic epithelial cells, oligodendrocyte progenitors, and neuroendocrine cells.
HBP00021  neutral sphingomyelinase  pmid:19519303 Sphingomyelin phosphodiesterase (EC 3.1.4.12, also known as neutral sphingomyelinase, sphingomyelinase, or SMase) is a hydrolase enzyme that is involved in sphingolipid metabolism reactions.
HBP00022  Neurodegeneration pmid:20202123 Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes.
HBP00023  amyloid-beta derived diffusible ligands pmid:19188609 soluble oligomeric forms of the amyloid beta peptide known as amyloid-derived diffusible ligands (ADDLs) are the toxic species responsible for neurodegeneration associated with Alzheimer's disease.
HBP00024  Hyperamylinemia pmid:23794448 increased secretion of the pancreatic hormone amylin
HBP00025  APOE e4 pmid:22701550 APOE e4 is a variant of APOE, it's APOE-ε4 (arg112, arg158).
HBP00026  N-AcGIP pmid:18234983 N-AcGIP is agonist of GIP
HBP00027  Pro3-GIP  pmid:18234983 Pro3-GIP is agonist of GIP
HBP00028  PI3K-Akt signaling pathway  pmid:22013558 PI3K-Akt signaling pathway is an intracellular signaling pathway important in regulating the cell cycle.It is described in KEGG.
HBP00029  Neurodegeneration pmid:12387894 Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons.
HBP00030  SecPS2NT  pmid:10078972 Don't know how to describe it properly
HBP00031  Argyrophilic Grain Disease  pmid:15658002 Argyrophilic grain disease (AGD) is an under-recognized, distinct, highly frequent sporadic tauopathy, with a prevalence reaching 31.3% in centenarians. 
HBP00032  granulovacuolar degeneration  pmid:17455299 Granulovacuolar degeneration (GVD) is one of the pathological hallmarks of Alzheimer's disease (AD), and it is defined as electron-dense granules within double membrane-bound cytoplasmic vacuoles.
